Determining the genetic structure of the SARS-CoV-2 virus and its mutations is a labour-intensive and tedious process, says Sylwia Krzętowska, head of the Epidemiological and Clinical Research Laboratory in Olsztyn. The nanopore sequencer (a device for sequencing nucleic acids) in Olsztyn analyses samples from four provinces.
Prolonged exposure to antibiotics leads to the gain of bacteria's ability to defeat the drugs designed to fight them. Thus, if such antibiotic-resistant bacteria cause the infection, the only chance to use a specialized virus called phage infecting specific bacteria species. It is a powerful weapon against deadly diseases. At the same time, the effective treatment depends on factors that would not be suspected for years to impact the successful therapy.